About the Company
We do not have any company description for Klotho Neurosciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Klotho Neurosciences, Inc.
Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market
Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based ...
Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology
Klotho Neurosciences, Inc. (Nasdaq: KLTO), announces that it signed a binding agreement to initiate manufacturing and ...
Klotho Neurosciences Delays Quarterly Report Filing
Klotho Neurosciences ( (KLTO) ) has released a notification of late filing.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...
Klotho Neurosciences Partners with AAVnerGene for Gene Therapy
Klotho Neurosciences ( ($KLTO) ) has provided an update. On August 12, 2025, Klotho Neurosciences announced a binding agreement with AAVnerGene ...
Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho ...
Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets Provided by PR Newswire Jul 22, 2025, 7:21:00 AM ...
Klotho Neurosciences, Inc. to Expand Development Programs Beyond ...
NEW YORK, July 24, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) (the "Company" or "Klotho") announced today that it is evaluating the acquisition of several complementary ...
Klotho Neurosciences, Inc. to Present at Biotech Showcase 2025 on ...
Klotho Neurosciences, Inc. announced that its CEO, Dr. Joseph Sinkule, will present at Biotech Showcase 2025 in San Francisco on January 14, 2025, during J.P. Morgan Healthcare Week.
KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY ...
NEW YORK, June 9, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company announced the findings of pre-clinical studies indicating the potential of ...
Klotho Neurosciences, Inc. and the Okinawa Research Center for ...
NEW YORK, June 24, 2025 /CNW/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene- based treatments to address neurological conditions, including ...
Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ ... - ABC27
Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented form ...
Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to ... - Nasdaq
--Klotho Neurosciences, Inc., announced that it is partnering with AAVnerGene Inc., a Rockville, MD- based innovation-driven biotech renowned for its transformative technologies in AAV ...
Similar Companies
Loading the latest forecasts...